Skip to main content
. Author manuscript; available in PMC: 2010 Mar 8.
Published in final edited form as: Biochim Biophys Acta. 2008 Aug 22;1792(5):454–469. doi: 10.1016/j.bbadis.2008.08.005

Table 2.

UK ADC: demographics and clinical indices

Diabetics Non-diabetics p-value
Demographics
N 50 89
Age at death, yrs (mean±SD) 84.7±8.0 88.2±6.7 <0.011
Sex (%F) 54 63 NS2
Formal education, yrs (mean±SD) 15.6±2.6 16.0±2.0 NS1
ApoE alleles (2/3/4), % 4/84/12 11/76/13 NS3
Last MMSE score (mean±SD) 26.4±5.1 24.4±7.4 NS1
Interval between last evaluation and death, yrs (mean±SD) 0.64 0.96 NS1
Clinical parameters
Depression, % 20 20 NS2
CABG, % 14 7 NS3
Peripheral vascular disease, % 26 15 NS2
TIA, % 14 8 NS2
Hypertension, % 64 55 NS2
Daily intake of drugs/meds (mean±SD) 12.2±7.7 19.8±8.5 <0.00011

The demographic and clinical characteristics between diabetics (N=50) and non-diabetics (N=89) in the BRAiNS program at the UK ADC. This group, which was recruited from non-demented individuals, has been described previously [245]. The demographic and clinical indices are similar between diabetics and non-diabetics. The clinical parameters were dichotomous (0 or 1) except for “Number of drugs” (range: 2–39). Definitions: ApoE = Apolipoprotein E; MMSE = Mini-mental status examination (0–30 scale); CABG = coronary artery bypass graft operation; TIA = history of transient ischemic attack(s).

Statistical tests:

1

Two-tailed Student’s t test

2

Chi-square

3

Fisher’s exact test.